Hutch News
Results per Page:
Infectious Diseases Society to honor Dr. Michael Boeckh
Hutch virus expert to deliver John F. Enders Lecture at Washington, D.C., conference
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
Scientists learn how common virus reactivates after transplantation
New Science paper describes how antibody-producing B cells, not disease-fighting T cells, protect against reactivation of cytomegalovirus
.jpg)
Rethinking an old viral foe
Why does a common virus plague bone marrow transplant patients? New study challenges dogma, opens door to new therapies.
With approval of new CMV drug for transplant patients, a legacy continues
Tissue samples from a clinical trial conducted decades ago yield new insights and treatments
Adam Geballe elected AAAS Fellow
Hutch virologist honored for revealing key players in molecular ‘arms race’ between viruses and hosts
Cytomegalovirus causes transient prior to lifelong infection
Schiffer Laboratory, Vaccine and Infectious Disease Division
With immunosequencing, what is past is prologue
From the Robins Lab, Public Health Sciences Division.
Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care
Celebrating faculty and staff achievements
New vaccine may prevent cytomegalovirus infection
Vaccine and Infectious Disease Institute researchers co-author study on vaccine with potential to prevent the most common virus transmitted by a pregnant woman to her unborn child